Cafepharma Today

November 16 2018 - AstraZeneca’s tremelimumab does not perform well in NSCLC trial
AstraZeneca’s tremelimumab does not perform well in NSCLC trial
Does AstraZeneca pay its CEO too much?
The latest on Brexit and the pharma industry
Boston Scientific plans $200M restructuring
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

submit a press release
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Fierce Pharma
Thursday, November 15, 2018 - 9:45am
tags:
Merck, vaccines, Congo, ebola virus
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wednesday, November 14, 2018 - 11:45pm
tags:
Pfizer, biosimilars, Amgen, Epogen, JNJ, Procrit, anemia
New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs
BioSpace
Wednesday, November 14, 2018 - 11:42pm
tags:
New Jersey, opioids, JNJ, Janssen
Billions Will Be Poured Into AI Drug Development
Forbes
Wednesday, November 14, 2018 - 4:56pm
tags:
artificial intelligence, drug development
Biotech Eli Lilly files for FDA approval of migraine drug lasmiditan
Fierce Biotech
Wednesday, November 14, 2018 - 4:50pm
tags:
Eli Lilly, migraines, FDA, Lasmiditan
This Small-Cap Biotech is Quietly Setting the Stage For a Big 2019
Motley Fool
Wednesday, November 14, 2018 - 4:42pm
tags:
Codexis, enzymes
What's coming? Pazdur, Marks and Woodcock discuss FDA changes
Endpoints
Wednesday, November 14, 2018 - 4:41pm
tags:
FDA
Report: Med device recalls down in Q3
Medical Design and Outsourcing
Wednesday, November 14, 2018 - 4:40pm
tags:
devices, recalls
Specialty drugs drive Rx spending increase, Blue Cross says
Biopharma Dive
Wednesday, November 14, 2018 - 4:39pm
tags:
drug spending, Blue Cross, specialty drugs
California, Massachusetts go toe-to-toe for title of best biotech hub
Biopharma Dive
Wednesday, November 14, 2018 - 4:36pm
tags:
California, Massachusetts, biotech
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
Fierce Pharma
Wednesday, November 14, 2018 - 11:57am
tags:
Novartis, Alcon, spinoffs, SEC, eye health
Merck's Keytruda picks up first-in-class survival win in esophageal cancer
Fierce Pharma
Wednesday, November 14, 2018 - 11:55am
tags:
Merck, Keytruda, esophageal cancer

Pages

Latest CP Wire Articles

bluebird bio SUCKSSS
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
TrialScope Unites Industry Leaders to Address Key Issues of Clinical Trial Disclosure and Transparency at 2018 Strategic Partner Meeting
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bicycle Therapeutics Named Best New Drug Developer at World ADC Awards
Ribometrix Pulls In $30 Million in Series A Round
CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis
FDA Grants Breakthrough Therapy Designation to First Oral Drug for Suicidal Bipolar Depression
FDA Accepts sNDA for Lynparza for Maintenance Therapy in Advanced Ovarian Cancer and Grants Priority Review

Latest Pharmagather Articles

Commercializing Cell and Gene Therapies with High-Touch Services
Drug Channels
Machine Learning: The Next Frontier in Commercial Planning
pharmexec technology
Healthcare Marketers: Being More Human Doesn t Mean Being Less Transparent
pharmexec marketing
Failure Shouldn’t Be Such an Orphan
In the Pipeline
Diabetes Researchers Make Novel Connections with Graph Technology
pharmexec technology
Bromopyruvate Revealed
In the Pipeline
Express Scripts Launches a New Formulary for a World Without Rebates. Will Plan Sponsors and Drug Makers Play Along?
Drug Channels
Use Digital Marketing To Listen To Your Customers
Digital Pharma Blog
The EU Open Access Fight Continues
In the Pipeline
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Progressive Care Inc. Announces Record-Breaking October 2018
Friday, November 16, 2018 - 8:00am
Data from PRO 140 (leronlimab) HIV Monotherapy Trial Selected for Presentation at CROI 2019
Friday, November 16, 2018 - 6:00am
Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights
Thursday, November 15, 2018 - 4:07pm
Invest Nebraska announces investment in White Dog Labs
Thursday, November 15, 2018 - 3:29pm
As Hospitals Work to Reduce Patient Safety Risk Caused by Running Out of Medications, The Drug Shortage App from LogicStream Health is Now Available to Control Drugs in Short Supply
Thursday, November 15, 2018 - 11:28am
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration
Thursday, November 15, 2018 - 9:00am
Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing
Thursday, November 15, 2018 - 8:00am
Lawrence Biggs, CEO of PreCheck Health Services, Inc., is Featured in an Exclusive New Audio Interview with SmallCapVoice.com
Thursday, November 15, 2018 - 8:00am
Gamma-Delta (γδ) T Cell Therapy Combined With Checkpoint Inhibition Shows Potential Synergies in Vitro for Treatment of Glioblastoma
Thursday, November 15, 2018 - 7:00am
Savaria Announces Record Revenue of $72 Million for Third Quarter of 2018
Wednesday, November 14, 2018 - 5:05pm

Breaking Healthcare News - powered by Seeking Alpha

Agios Pharma's AG-881 shows potential treatment effect in early-stage brain/spinal cord cancer study
Friday, November 16, 2018 - 8:17am
Reliq Health Technologies announces resignation of CFO
Friday, November 16, 2018 - 8:11am
BeiGene's pamiparib shows positive action in Phase 1/2 brain cancer study
Friday, November 16, 2018 - 7:56am
European advisory group backs Sanofi's fexinidazole for sleeping sickness
Friday, November 16, 2018 - 7:43am
Britain's NICE on board with Novartis' Kymriah for ALL
Friday, November 16, 2018 - 7:34am
AstraZeneca's Imfinzi flunks late-stage study in first-line metastatic lung cancer
Friday, November 16, 2018 - 7:22am
CASI Pharmaceuticals to build GMP manufacturing site in Wuxi, China
Friday, November 16, 2018 - 7:10am
Translate Bio up 22%
Thursday, November 15, 2018 - 1:34pm
Adial Pharma up 7% after business update
Thursday, November 15, 2018 - 1:01pm
Retractable Technologies reports Q3 results
Thursday, November 15, 2018 - 12:51pm

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.